Download PDF
1 / Pages

Other users also viewed these articles

Juvenile idiopathic arthritis in the young adult. Methodology, objectives, and initial data from the JUVENSER registry Juan José Bethencourt-Baute; Nuria Montero; Andrea M. Zacarias; Juan Carlos Nieto; Mireia López-Corbeto; Alina Boteanu; Marta Medrano; Gisela Díaz-Cordovés Rego; Carmen Vargas-Lebron; Sergio Machín-García; Lorena Expósito; Ana Paula Cacheda; Pilar Bernabeu; Raúl Veroz-González; Olaia Fernández; Eugenia Enriquez Merayo; Vicenç Torrente-Segarra; María Dolores Fernández-Alba; María Luz Gamir; Juan Carlos López-Robledillo; Jordi Antón; Lucía Otero; Sagrario Bustabad;
Reumatol Clin. 2023;19:328-33
Extension of the RENACER Study: 12-Month Efficacy, Safety and Certolizumab PEGol Survival in 501 Rheumatoid Arthritis Patients Vicenç Torrente-Segarra; Manuel Fernández Prada; Rosa Expósito; Noemí Patricia Garrido Puñal; Amalia Sánchez-Andrade; José Ramón Lamúa-Riazuelo; Alejandro Olivé; Juan Víctor Tovar;
Reumatol Clin. 2021;17:57-8
Effectiveness and safety of rituximab in systemic lupus erythematosus: A case series describing the experience of 2 centres Vicenç Juan Gómez; Irene Carrión-Barberá; Tarek Carlos Salman Monte; Asunción Acosta; Vicenç Torrente-Segarra; Jordi Monfort;
Reumatol Clin. 2020;16P2:391-5